Trends in Nephrology: from treating kidney disease to maintaining kidney health [0.03%]
nephrology趋势:从治疗肾脏疾病到保持肾脏健康
Alberto Ortiz
Alberto Ortiz
Peptide Epitope Mapping of Anti-nephrin Autoantibodies in Focal Segmental Glomerulosclerosis [0.03%]
抗肾小球内皮细胞抗体的肽抗原表位映射
Pan Liu,Xinfang Xie,Qian Jin et al.
Pan Liu et al.
Cyclosporin a- versus tacrolimus-specific lesions in calcineurin inhibitor nephrotoxicity [0.03%]
环孢素A和他克莫司对钙调神经磷酸酶抑制剂肾毒性的特异性损伤作用研究
Mingzhen Su,Hasan Demirci,Bilgin Osmanodja et al.
Mingzhen Su et al.
Background: Calcineurin inhibitors (CNI) such as cyclosporine A (CsA) and tacrolimus (Tac) have revolutionized solid organ transplantation. CNI-associated nephrotoxicity (CNIT) remains a concern. Addressing differences be...
Essential but elusive: the availability of suitable salt treatments for tubulopathies [0.03%]
不可或缺但难以寻觅:适合治疗肾小管疾病的盐疗法供给状况
Detlef Bockenhauer,Gema Ariceta,Francesco Emma et al.
Detlef Bockenhauer et al.
María Jesús Izquierdo-Ortiz,Carolina Gracia-Iguacel,Badawi Hijazi-Prieto et al.
María Jesús Izquierdo-Ortiz et al.
Background and hypothesis: Sex differences in chronic kidney disease (CKD) are recognised, but how they change across the menopausal transition-and how this affects therapeutic opportunities in primary care-remains unclea...
Sihem Sellami,Thomas Verissimo,Delal Dalga et al.
Sihem Sellami et al.
Gluconeogenesis, responsible for maintaining systemic glucose availability during fasting, has long been thought to be a process mainly performed by the liver. Over the past decades, physiological and molecular studies have established the ...
Efficacy and safety of the cystic fibrosis transmembrane conductance regulator inhibitor GLPG2737 for autosomal dominant polycystic kidney disease: phase 2a MANGROVE study [0.03%]
囊性纤维化跨膜传导调节剂抑制剂GLPG2737治疗常染色体显性多囊肾病的疗效和安全性:2期MANGROVE研究
Ron T Gansevoort,Miguel Hueso,Antonio Pisani et al.
Ron T Gansevoort et al.
Background: There is a need for improved disease-targeting therapies for autosomal dominant polycystic kidney disease (ADPKD). This study evaluated the efficacy and safety of GLPG2737, a cystic fibrosis transmembrane cond...
Mathilde Berghmans,François Seghers,Safak Mirioglu et al.
Mathilde Berghmans et al.
Complement inhibitors are increasingly used in kidney diseases, ranging from complement-mediated thrombotic microangiopathies to glomerulonephritis. Because complement is central to host defence against encapsulated bacteria, therapeutic bl...
Yongzhong Zhong,Yunyun Liu,Dan Zhou et al.
Yongzhong Zhong et al.
Background and hypothesis: Protocadherin-7 (PCDH7) is a newly discovered rare autoantigen in membranous nephropathy (MN). Data about PCDH7-positive MN are limited. We investigate the clinicopathological characteristics an...